Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of cefpirome and moxifloxacin in plasma and abscess fluid
2005-004455-35Phase 4Completed
- Sponsor
- Department of Clinical Pharmacology, Medical University of Vienna
- Start
- Oct 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefpirome and moxifloxacin in abscess and Abdominal cyst (2 arms), sponsored by Department of Clinical Pharmacology, Medical University of Vienna. Primary endpoints: Cefpirome concentrations in abscess fluid, Moxifloxacin concentrations in abscess fluid and 3 more. Started Oct 2005; status: completed.
02
Drugs
cefpiromemoxifloxacin
03
Conditions
abscessAbdominal cyst
Beyond the preview
Go deeper on 2005-004455-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004455-35.